LBL-2016 for Children or Adolescents in China
Phase 3
Active, not recruiting
- Conditions
- Lymphoblastic Lymphoma
- Registration Number
- NCT02845882
- Lead Sponsor
- Children's Cancer Group, China
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients must have newly diagnosed lymphoblastic lymphoma; Patients shall have had<br> no prior cytotoxic chemotherapy with the exception of steroids (<420mg/m2)<br><br>Exclusion Criteria:<br><br> - Patients with Down syndrome;<br><br> - Morphologically unclassifiable lymphoma<br><br> - Patients with congenital immunodeficiency, chromosomal breakage syndrome, prior<br> organ transplantation, previous malignancy of any type, or known positive HIV<br> serology.<br><br> - Evidence of pregnancy or lactation period.<br><br> - Ph+ lymphoblastic lymphoma
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Event free survival for the whole cohort;Event free survival for patients in High risk group
- Secondary Outcome Measures
Name Time Method Overall survival for all patients